» Articles » PMID: 29207749

Cirrhosis of Liver and Diabetes Mellitus: The Diabolic Duo?

Overview
Specialty General Medicine
Date 2017 Dec 7
PMID 29207749
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Cirrhosis of the liver and diabetes mellitus are two chronic illnesses with significant impact on the quality of life. Studies from different part of the world have shown the combination to be associated with higher incidence of complications of cirrhosis and reduced survival. However, data on the impact of pre-cirrhotic and post-cirrhotic diabetes on cirrhosis is minimal.

Aim: The aim of the study was to determine the complications of cirrhosis patients with and without co-existent DM and to compare the relation between cirrhosis patients with antecedent DM and hepatogenous DM.

Materials And Methods: The present prospective study was conducted at a tertiary care hospital in Kerala, India, over a period of three years. Cirrhosis patients with and without diabetes, along with subcategorization as antecedent and hepatogenous diabetes, were studied for various complications and outcome including death. Chi-square and Mann-whitney tests were used for comparing data.

Results: Patients with cirrhosis and diabetes had higher incidence of gall stones (27.6% versus 13.2%; p=0.008) and urinary infection (29.3% versus 7.5%; p=<0.001). Incidence of hepatocellular carcinoma and mortality were similar between the groups. Patients with antecedent diabetes and hepatogenous diabetes were similar with respect to complications and mortality. Child-Turcotte-Pugh (CTP) score, Model for End stage Liver Disease (MELD) score, urinary tract and respiratory infections and duration of cirrhosis were independent predictors of mortality in patients with cirrhosis.

Conclusion: Coexistent diabetes mellitus increases the incidence of complications and hospitalizations in cirrhosis patients but without impact on mortality rates. There is no significant morbidity or mortality difference between cirrhotics with antecedent diabetes and hepatogenous diabetes.

Citing Articles

Vitamin C Alleviates the Risk of Gestational Diabetes Mellitus Associated With Exposure to Metals.

Wang Y, Wu W, Zhang P, Chen X, Feng Y, Yang H J Diabetes Res. 2024; 2024:1298122.

PMID: 39035682 PMC: 11260216. DOI: 10.1155/2024/1298122.


Endocrinology for the hepatologist.

Afraz S, Kapila N Clin Liver Dis (Hoboken). 2023; 22(1):1-6.

PMID: 37521181 PMC: 10378804. DOI: 10.1097/CLD.0000000000000037.


Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders.

Yaribeygi H, Maleki M, Jamialahmadi T, Moallem S, Sahebkar A EXCLI J. 2023; 22:403-414.

PMID: 37346806 PMC: 10279968. DOI: 10.17179/excli2023-6022.


Hepatogenous diabetes: Knowledge, evidence, and skepticism.

Kumar R, Garcia-Compean D, Maji T World J Hepatol. 2022; 14(7):1291-1306.

PMID: 36158904 PMC: 9376767. DOI: 10.4254/wjh.v14.i7.1291.


Effects of Achieving Sustained Virologic Response after Direct-Acting Antiviral Agents on Long-Term Liver Fibrosis in Diabetics vs. in Non-Diabetic Patients with Chronic Hepatitis C Infection.

Popescu M, Firu D, Padureanu V, Marginean C, Mitrut R, Arsene A Biomedicines. 2022; 10(9).

PMID: 36140194 PMC: 9495608. DOI: 10.3390/biomedicines10092093.


References
1.
Kamath P, Kim W . The model for end-stage liver disease (MELD). Hepatology. 2007; 45(3):797-805. DOI: 10.1002/hep.21563. View

2.
Konijn A, Hershko C . Ferritin synthesis in inflammation. I. Pathogenesis of impaired iron release. Br J Haematol. 1977; 37(1):7-16. View

3.
PETRIDES A, Stanley T, Matthews D, Vogt C, Bush A, Lambeth H . Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity. Hepatology. 1998; 28(1):141-9. DOI: 10.1002/hep.510280119. View

4.
Pickup J, Chusney G, Thomas S, Burt D . Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci. 2000; 67(3):291-300. DOI: 10.1016/s0024-3205(00)00622-6. View

5.
Garcia-Compean D, Jaquez-Quintana J, Maldonado-Garza H . Hepatogenous diabetes. Current views of an ancient problem. Ann Hepatol. 2009; 8(1):13-20. View